LIPINUTRAGEN
Launch date
Company register number BO0452721
Bologna Emilia-Romagna (HQ)
Financials
Estimates*
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Revenues | <1m | <1m | <1m | <1m | <1m | <1m | <1m |
% growth | (10 %) | 45 % | (30 %) | (8 %) | (27 %) | 32 % | (15 %) |
EBITDA | <1m | <1m | <1m | <1m | - | <1m | (<1m) |
% EBITDA margin | 11 % | 14 % | 7 % | 5 % | - | 6 % | (12 %) |
Profit | <1m | <1m | <1m | (<1m) | (<1m) | (<1m) | (<1m) |
% profit margin | 3 % | 8 % | 1 % | (2 %) | (52 %) | (3 %) | (18 %) |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
€80.0k | Grant | ||
Total Funding | €80.0k |
Recent News about LIPINUTRAGEN
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.